MindWalk Holdings Corp (HYFT) NPV

Sell:$2.43Buy:$2.52Price decreased$0.17 (6.51%)

Prices delayed by at least 15 minutes
Sell:$2.43
Buy:$2.52
Change:Price decreased$0.17 (6.51%)
Deal now
Prices delayed by at least 15 minutes
Sell:$2.43
Buy:$2.52
Change:Price decreased$0.17 (6.51%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Key people

Jennifer Lynne Bath
President, Chief Executive Officer, Director
Joseph Scheffler
Interim Chief Financial Officer
Kari Graber
Vice President - Commercial Services
Shuji Sato
Vice President - Innovative Solutions
Jonathan I. Lieber
Director
Kamil Isaev
Independent Director
Dirk Witters
Independent Director
Click to see more

Key facts

  • Shares in issue
    46.69m
  • EPIC
    HYFT
  • ISIN
    CA6026871054
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $127.00m
  • Employees
    102
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.